- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Asembia 2022 Summit to Address Biosimilar Adoption, Policy Implications for Specialty Pharmacy
Numerous topics will be addressed at this year's Asembia Specialty Pharmacy Summit, held in-person in Las Vegas from May 2 through 5, including updates on cell and gene therapies and insights on the future of the industry.
Asembia’s 2022 Specialty Pharmacy Summit is scheduled to take place next week from May 2-5 in Las Vegas, Nevada, and will feature keynote speaker Scott Gottlieb, MD, former commissioner of the FDA and senior advisor at CMS.
Sessions and panels will include discussions on all things specialty pharmacy, including advancements in treatment therapies, market access strategies, and the pharmaceutical pipeline.
The organization’s last meeting was held in October 2021, postponed due to COVID-19, while next week’s gathering will see a return to the regular Spring timeslot.
Continuing education courses run the gamut of treatments for disease states, including opportunities to learn about managing atopic dermatitis in pediatric patients and a review for specialty pharmacists on management of idiopathic pulmonary fibrosis.
Featured sessions also include updates on popular topics such as the role of pharmacists in driving future biosimilar adoption and the importance of protecting patient data alongside the risks to national data security.
Policy discussions will focus on challenges navigating state regulations, a look at President Biden’s health agenda in an election year, and the passage of the 30-year anniversary of the Public Health Service (PHS) 340B program.
On the payer side, experts are slated to discuss the slow uptake of digital therapeutics while representatives from Amazon Pharmacy and Eli Lilly will present a session called “Bringing Ecommerce Insights to Pharmacy.”
Updates on cell and gene therapies will be provided along with legal considerations on specialty pharmacies engaging in different patient infusion models.
The agenda features several patient-centered discussions including one on overcoming social determinates of health via specialized teams, presented by representatives from Walgreens.
An additional session titled “Navigating the Pandemic With EUA Therapies,” will address issues raised by supply challenges, therapy indications and time constraints, while “Understanding the Use of Patient-Reported Outcomes in Improving Pharmacy Care,” will highlight CVS’ efforts to optimize its supply management practices through personalized digital engagement.
Pharmacy accreditation, shifts in sites of care, and value based contracting will also be discussed, along with insights on medication adherence and financial barriers that my lead to prescription abandonment.
The conference will take place at the Wynn & Encore hotel with over 5000 industry attendees expected at the in-person event.
Keep an eye on our Asembia conference page for live coverage from Las Vegas, starting May 2.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
